skip to content
Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy Preview this item
ClosePreview this item
Checking...

Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy

Author: Lennart Domellöf
Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg, 1989.
Series: ESO Monographs, European School of Oncology.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli nary approach which is difficult for the Universities to put into practice since their system is mainly  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Lennart Domellöf
ISBN: 9783642747090 3642747094
OCLC Number: 851775506
Description: 1 online resource (vii, 107 pages 31 illustrations).
Contents: Analgesic Drugs in Palliative Care --
Pharmacokinetic Aspects of Drug-Drug and Drug-Plastic Interactions with Anticancer Drugs --
Immunotherapy and Interactions of Cytokines in the Host --
The Rationale of Intraarterial Chemotherapy of Liver Cancer --
Chemoembolisation in Regional Chemotherapy --
Optimised Treatment Modalities for Hypoxic Tumour Cells --
Drug Delivery to Cancer Patients in Home Care: Experience with Intraarterial and Intravenous Chemotherapy.
Series Title: ESO Monographs, European School of Oncology.
Responsibility: edited by Lennart Domellöf.

Abstract:

The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of on cology.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.

Similar Items

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/851775506> # Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy
    a schema:CreativeWork, schema:Book, schema:MediaObject ;
   library:oclcnum "851775506" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/gw> ;
   library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/21490045#Place/berlin_heidelberg> ; # Berlin, Heidelberg
   schema:about <http://dewey.info/class/616.994/e23/> ;
   schema:about <http://id.worldcat.org/fast/976610> ; # Internal medicine
   schema:about <http://id.worldcat.org/fast/1153364> ; # Toxicology
   schema:about <http://id.worldcat.org/fast/1139351> ; # Surgery
   schema:about <http://id.worldcat.org/fast/1014893> ; # Medicine
   schema:about <http://id.worldcat.org/fast/1045739> ; # Oncology
   schema:bookFormat schema:EBook ;
   schema:creator <http://viaf.org/viaf/54874756> ; # Lennart Domellöf
   schema:datePublished "1989" ;
   schema:description "The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of on cology."@en ;
   schema:description "Analgesic Drugs in Palliative Care -- Pharmacokinetic Aspects of Drug-Drug and Drug-Plastic Interactions with Anticancer Drugs -- Immunotherapy and Interactions of Cytokines in the Host -- The Rationale of Intraarterial Chemotherapy of Liver Cancer -- Chemoembolisation in Regional Chemotherapy -- Optimised Treatment Modalities for Hypoxic Tumour Cells -- Drug Delivery to Cancer Patients in Home Care: Experience with Intraarterial and Intravenous Chemotherapy."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/21490045> ;
   schema:genre "Electronic books"@en ;
   schema:inLanguage "en" ;
   schema:isPartOf <http://experiment.worldcat.org/entity/work/data/21490045#Series/eso_monographs_european_school_of_oncology> ; # ESO Monographs, European School of Oncology.
   schema:isSimilarTo <http://worldcat.org/entity/work/data/21490045#CreativeWork/> ;
   schema:name "Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy"@en ;
   schema:productID "851775506" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/851775506#PublicationEvent/berlin_heidelberg_springer_berlin_heidelberg_1989> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/21490045#Agent/springer_berlin_heidelberg> ; # Springer Berlin Heidelberg
   schema:url <http://dx.doi.org/10.1007/978-3-642-74709-0> ;
   schema:url <http://link.springer.com/10.1007/978-3-642-74709-0> ;
   schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=3093738> ;
   schema:workExample <http://dx.doi.org/10.1007/978-3-642-74709-0> ;
   schema:workExample <http://worldcat.org/isbn/9783642747090> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/851775506> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/21490045#Agent/springer_berlin_heidelberg> # Springer Berlin Heidelberg
    a bgn:Agent ;
   schema:name "Springer Berlin Heidelberg" ;
    .

<http://experiment.worldcat.org/entity/work/data/21490045#Place/berlin_heidelberg> # Berlin, Heidelberg
    a schema:Place ;
   schema:name "Berlin, Heidelberg" ;
    .

<http://experiment.worldcat.org/entity/work/data/21490045#Series/eso_monographs_european_school_of_oncology> # ESO Monographs, European School of Oncology.
    a bgn:PublicationSeries ;
   schema:hasPart <http://www.worldcat.org/oclc/851775506> ; # Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy
   schema:name "ESO Monographs, European School of Oncology." ;
   schema:name "ESO Monographs, European School of Oncology" ;
    .

<http://id.worldcat.org/fast/1014893> # Medicine
    a schema:Intangible ;
   schema:name "Medicine"@en ;
    .

<http://id.worldcat.org/fast/1045739> # Oncology
    a schema:Intangible ;
   schema:name "Oncology"@en ;
    .

<http://id.worldcat.org/fast/1139351> # Surgery
    a schema:Intangible ;
   schema:name "Surgery"@en ;
    .

<http://id.worldcat.org/fast/1153364> # Toxicology
    a schema:Intangible ;
   schema:name "Toxicology"@en ;
    .

<http://id.worldcat.org/fast/976610> # Internal medicine
    a schema:Intangible ;
   schema:name "Internal medicine"@en ;
    .

<http://link.springer.com/10.1007/978-3-642-74709-0>
   rdfs:comment "from Springer" ;
   rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://viaf.org/viaf/54874756> # Lennart Domellöf
    a schema:Person ;
   schema:familyName "Domellöf" ;
   schema:givenName "Lennart" ;
   schema:name "Lennart Domellöf" ;
    .

<http://worldcat.org/entity/work/data/21490045#CreativeWork/>
    a schema:CreativeWork ;
   schema:description "Print version:" ;
   schema:isSimilarTo <http://www.worldcat.org/oclc/851775506> ; # Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy
    .

<http://worldcat.org/isbn/9783642747090>
    a schema:ProductModel ;
   schema:isbn "3642747094" ;
   schema:isbn "9783642747090" ;
    .

<http://www.worldcat.org/title/-/oclc/851775506>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
   schema:about <http://www.worldcat.org/oclc/851775506> ; # Drug Delivery in Cancer Treatment II : Symptom Control, Cytokines, Chemotherapy
   schema:dateModified "2017-12-24" ;
   void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.